Healthcare -
Biotechnology - NASDAQ - US
$ 2.95
-10.3 %
$ 2.15 B
Market Cap
-3.28
P/E
IBRX - OPERATING INCOME
Operating Income IBRX - ImmunityBio, Inc.
-362 M
LAST VALUE
-4.73%
2 YEAR CAGR
-29.78%
5 YEAR CAGR
-66.08%
10 YEAR CAGR